SELLAS Life Sciences (SLS) Other Non Operating Income (2010 - 2019)
SELLAS Life Sciences (SLS) reported Other Non Operating Income of $668000.0 for Q4 2019, down 12.79% on a QoQ basis from $766000.0 in Q3 2018.
SELLAS Life Sciences (SLS) has 9 years of Other Non Operating Income data on file, last reported at $668000.0 in Q4 2019.
- Quarterly Other Non Operating Income changed N/A year-over-year to $668000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $1.4 million (up 87.21% YoY) and the FY2020 annual result came in at $208000.0, down 68.86% from the prior year.
- Other Non Operating Income declined to $668000.0 in Q4 2019 per SLS's latest filing, from $766000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $766000.0 in Q3 2018 and bottomed at -$321000.0 in Q1 2015.
- The 4-year median for Other Non Operating Income is $307000.0 (2015), against an average of $253285.7.
- Peak annual rise in Other Non Operating Income reached 116.9% in 2015, while the deepest fall reached 94.55% in 2015.
- Tracing SLS's Other Non Operating Income over 4 years: stood at $440000.0 in 2015, then plunged by 138.64% to -$170000.0 in 2016, then soared by 550.59% to $766000.0 in 2018, then slipped by 12.79% to $668000.0 in 2019.
- Per Business Quant, the three latest SLS Other Non Operating Income figures stand at $668000.0 (Q4 2019), $766000.0 (Q3 2018), and -$170000.0 (Q1 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 668,000.00 |
| Sep 30, 2018 | 766,000.00 |
| Mar 31, 2016 | -170,000.00 |
| Dec 31, 2015 | 440,000.00 |
| Sep 30, 2015 | 307,000.00 |
| Jun 30, 2015 | 83,000.00 |
| Mar 31, 2015 | -321,000.00 |
| Dec 31, 2014 | 229,000.00 |
| Sep 30, 2014 | 597,000.00 |
| Jun 30, 2014 | -491,000.00 |
| Mar 31, 2014 | -165,000.00 |
| Dec 31, 2013 | 2.14 Mn |
| Sep 30, 2013 | 693,000.00 |
| Jun 30, 2013 | -70,000.00 |
| Mar 31, 2013 | -5.44 Mn |
| Dec 31, 2012 | 11.55 Mn |
| Sep 30, 2012 | -733,000.00 |
| Jun 30, 2012 | 5.93 Mn |
| Mar 31, 2012 | -18.27 Mn |
| Dec 31, 2011 | 7.36 Mn |
| Sep 30, 2011 | -397,000.00 |
| Jun 30, 2011 | 685,000.00 |
| Mar 31, 2011 | 1.44 Mn |
| Dec 31, 2010 | 1.87 Mn |
| Sep 30, 2010 | -419,000.00 |
| Jun 30, 2010 | 2.61 Mn |